HDAC4 and cardiac hypertrophy: Several studies support a role for miR-22 in cardiac hypertrophy via targeting Pten, Sirtuin 1 (Sirt1), and histone deacetylase 4 (Hdac4) as evidenced by results from transgenic mouse models and multiple induced-hypertrophic cellular platforms [35,36,37].